Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
4 nM for PARP1 in a cell-free assay
Casticin (0-40 μM) dose-dependently inhibits the proliferation of LX2 cells
GNE-049 is further evaluated in a rat single dose (30-250 mg/kg QD) toxicokinetic study
Smiles: COC(=O)N[C@H]1CCC[C@@H]1[C@@](CN1CCC1)(C1CCN(CC2(CN(C2)C2=CC=C(C=C2)S(=O)(=O)N2C[C@@H]3C[C@H]2CN3C(=O)C=C)OC)CC1)C1=CC(F)=CC=C1
Formula: C19H18O4
O-1821 Catalog No.:M22754-C 4 nM for PARP1 inO 1821 is an cannabidiol analog with similar structure to O 1918, a selective antagonist of abnormal cannabidiol. Abnormal cannabidiol, a synthetic regioisomer of cannabidiol, fails to elicit either central cannabinoid (CB1) or peripheral cannabinoid (CB2) receptors and is lack of psychotropic activity. It can induce endothelium dependent vasodilation through a CB1 CB2 nitric oxide independent mechanism. In vitro: O 1821 is a cannabidiol analog with
US$ 56.95
US$ 65.00
US$ 66.95
US$ 27.95
US$ 31.46
US$ 18.47